Global Adipose Derived Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Adipose Derived Stem Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.

The Global Info Research report includes an overview of the development of the Adipose Derived Stem Cell Therapy industry chain, the market status of Therapeutic Application (Autologous Stem Cells, Allogeneic Stem Cells), Research Application (Autologous Stem Cells, Allogeneic Stem Cells), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Adipose Derived Stem Cell Therapy.

Regionally, the report analyzes the Adipose Derived Stem Cell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Adipose Derived Stem Cell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Adipose Derived Stem Cell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Adipose Derived Stem Cell Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Autologous Stem Cells, Allogeneic Stem Cells).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Adipose Derived Stem Cell Therapy market.

Regional Analysis: The report involves examining the Adipose Derived Stem Cell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Adipose Derived Stem Cell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Adipose Derived Stem Cell Therapy:
Company Analysis: Report covers individual Adipose Derived Stem Cell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Adipose Derived Stem Cell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Therapeutic Application, Research Application).

Technology Analysis: Report covers specific technologies relevant to Adipose Derived Stem Cell Therapy. It assesses the current state, advancements, and potential future developments in Adipose Derived Stem Cell Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Adipose Derived Stem Cell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Adipose Derived Stem Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Autologous Stem Cells
    Allogeneic Stem Cells

Market segment by Application
    Therapeutic Application
    Research Application

Market segment by players, this report covers
    AlloCure
    Antria
    Celgene Corporation
    Cellleris
    Corestem
    Cytori Therapeutics
    Intrexon
    Mesoblast
    Pluristem Therapeutics
    Tissue Genesis
    BioRestorative Therapies
    Celltex Therapeutics Corporation
    iXCells Biotechnologies
    Pluristem Therapeutics
    Cyagen
    Lonza

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Adipose Derived Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Adipose Derived Stem Cell Therapy, with revenue, gross margin and global market share of Adipose Derived Stem Cell Therapy from 2019 to 2024.
Chapter 3, the Adipose Derived Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Adipose Derived Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Adipose Derived Stem Cell Therapy.
Chapter 13, to describe Adipose Derived Stem Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Adipose Derived Stem Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Adipose Derived Stem Cell Therapy by Type
        1.3.1 Overview: Global Adipose Derived Stem Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Autologous Stem Cells
        1.3.4 Allogeneic Stem Cells
    1.4 Global Adipose Derived Stem Cell Therapy Market by Application
        1.4.1 Overview: Global Adipose Derived Stem Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Therapeutic Application
        1.4.3 Research Application
    1.5 Global Adipose Derived Stem Cell Therapy Market Size & Forecast
    1.6 Global Adipose Derived Stem Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Adipose Derived Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Adipose Derived Stem Cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Adipose Derived Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Adipose Derived Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Adipose Derived Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Adipose Derived Stem Cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Adipose Derived Stem Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 AlloCure
        2.1.1 AlloCure Details
        2.1.2 AlloCure Major Business
        2.1.3 AlloCure Adipose Derived Stem Cell Therapy Product and Solutions
        2.1.4 AlloCure Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 AlloCure Recent Developments and Future Plans
    2.2 Antria
        2.2.1 Antria Details
        2.2.2 Antria Major Business
        2.2.3 Antria Adipose Derived Stem Cell Therapy Product and Solutions
        2.2.4 Antria Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Antria Recent Developments and Future Plans
    2.3 Celgene Corporation
        2.3.1 Celgene Corporation Details
        2.3.2 Celgene Corporation Major Business
        2.3.3 Celgene Corporation Adipose Derived Stem Cell Therapy Product and Solutions
        2.3.4 Celgene Corporation Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Celgene Corporation Recent Developments and Future Plans
    2.4 Cellleris
        2.4.1 Cellleris Details
        2.4.2 Cellleris Major Business
        2.4.3 Cellleris Adipose Derived Stem Cell Therapy Product and Solutions
        2.4.4 Cellleris Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Cellleris Recent Developments and Future Plans
    2.5 Corestem
        2.5.1 Corestem Details
        2.5.2 Corestem Major Business
        2.5.3 Corestem Adipose Derived Stem Cell Therapy Product and Solutions
        2.5.4 Corestem Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Corestem Recent Developments and Future Plans
    2.6 Cytori Therapeutics
        2.6.1 Cytori Therapeutics Details
        2.6.2 Cytori Therapeutics Major Business
        2.6.3 Cytori Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
        2.6.4 Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Cytori Therapeutics Recent Developments and Future Plans
    2.7 Intrexon
        2.7.1 Intrexon Details
        2.7.2 Intrexon Major Business
        2.7.3 Intrexon Adipose Derived Stem Cell Therapy Product and Solutions
        2.7.4 Intrexon Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Intrexon Recent Developments and Future Plans
    2.8 Mesoblast
        2.8.1 Mesoblast Details
        2.8.2 Mesoblast Major Business
        2.8.3 Mesoblast Adipose Derived Stem Cell Therapy Product and Solutions
        2.8.4 Mesoblast Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Mesoblast Recent Developments and Future Plans
    2.9 Pluristem Therapeutics
        2.9.1 Pluristem Therapeutics Details
        2.9.2 Pluristem Therapeutics Major Business
        2.9.3 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
        2.9.4 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Pluristem Therapeutics Recent Developments and Future Plans
    2.10 Tissue Genesis
        2.10.1 Tissue Genesis Details
        2.10.2 Tissue Genesis Major Business
        2.10.3 Tissue Genesis Adipose Derived Stem Cell Therapy Product and Solutions
        2.10.4 Tissue Genesis Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Tissue Genesis Recent Developments and Future Plans
    2.11 BioRestorative Therapies
        2.11.1 BioRestorative Therapies Details
        2.11.2 BioRestorative Therapies Major Business
        2.11.3 BioRestorative Therapies Adipose Derived Stem Cell Therapy Product and Solutions
        2.11.4 BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 BioRestorative Therapies Recent Developments and Future Plans
    2.12 Celltex Therapeutics Corporation
        2.12.1 Celltex Therapeutics Corporation Details
        2.12.2 Celltex Therapeutics Corporation Major Business
        2.12.3 Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Product and Solutions
        2.12.4 Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Celltex Therapeutics Corporation Recent Developments and Future Plans
    2.13 iXCells Biotechnologies
        2.13.1 iXCells Biotechnologies Details
        2.13.2 iXCells Biotechnologies Major Business
        2.13.3 iXCells Biotechnologies Adipose Derived Stem Cell Therapy Product and Solutions
        2.13.4 iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 iXCells Biotechnologies Recent Developments and Future Plans
    2.14 Pluristem Therapeutics
        2.14.1 Pluristem Therapeutics Details
        2.14.2 Pluristem Therapeutics Major Business
        2.14.3 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
        2.14.4 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Pluristem Therapeutics Recent Developments and Future Plans
    2.15 Cyagen
        2.15.1 Cyagen Details
        2.15.2 Cyagen Major Business
        2.15.3 Cyagen Adipose Derived Stem Cell Therapy Product and Solutions
        2.15.4 Cyagen Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Cyagen Recent Developments and Future Plans
    2.16 Lonza
        2.16.1 Lonza Details
        2.16.2 Lonza Major Business
        2.16.3 Lonza Adipose Derived Stem Cell Therapy Product and Solutions
        2.16.4 Lonza Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Lonza Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Adipose Derived Stem Cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Adipose Derived Stem Cell Therapy by Company Revenue
        3.2.2 Top 3 Adipose Derived Stem Cell Therapy Players Market Share in 2023
        3.2.3 Top 6 Adipose Derived Stem Cell Therapy Players Market Share in 2023
    3.3 Adipose Derived Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Adipose Derived Stem Cell Therapy Market: Region Footprint
        3.3.2 Adipose Derived Stem Cell Therapy Market: Company Product Type Footprint
        3.3.3 Adipose Derived Stem Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Adipose Derived Stem Cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Adipose Derived Stem Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Adipose Derived Stem Cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2030)
    6.3 North America Adipose Derived Stem Cell Therapy Market Size by Country
        6.3.1 North America Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Adipose Derived Stem Cell Therapy Market Size by Country
        7.3.1 Europe Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Adipose Derived Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America Adipose Derived Stem Cell Therapy Market Size by Country
        9.3.1 South America Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Adipose Derived Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Adipose Derived Stem Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Adipose Derived Stem Cell Therapy Market Drivers
    11.2 Adipose Derived Stem Cell Therapy Market Restraints
    11.3 Adipose Derived Stem Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Adipose Derived Stem Cell Therapy Industry Chain
    12.2 Adipose Derived Stem Cell Therapy Upstream Analysis
    12.3 Adipose Derived Stem Cell Therapy Midstream Analysis
    12.4 Adipose Derived Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Adipose Derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Adipose Derived Stem Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Adipose Derived Stem Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Adipose Derived Stem Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. AlloCure Company Information, Head Office, and Major Competitors
    Table 6. AlloCure Major Business
    Table 7. AlloCure Adipose Derived Stem Cell Therapy Product and Solutions
    Table 8. AlloCure Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. AlloCure Recent Developments and Future Plans
    Table 10. Antria Company Information, Head Office, and Major Competitors
    Table 11. Antria Major Business
    Table 12. Antria Adipose Derived Stem Cell Therapy Product and Solutions
    Table 13. Antria Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Antria Recent Developments and Future Plans
    Table 15. Celgene Corporation Company Information, Head Office, and Major Competitors
    Table 16. Celgene Corporation Major Business
    Table 17. Celgene Corporation Adipose Derived Stem Cell Therapy Product and Solutions
    Table 18. Celgene Corporation Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Celgene Corporation Recent Developments and Future Plans
    Table 20. Cellleris Company Information, Head Office, and Major Competitors
    Table 21. Cellleris Major Business
    Table 22. Cellleris Adipose Derived Stem Cell Therapy Product and Solutions
    Table 23. Cellleris Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Cellleris Recent Developments and Future Plans
    Table 25. Corestem Company Information, Head Office, and Major Competitors
    Table 26. Corestem Major Business
    Table 27. Corestem Adipose Derived Stem Cell Therapy Product and Solutions
    Table 28. Corestem Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Corestem Recent Developments and Future Plans
    Table 30. Cytori Therapeutics Company Information, Head Office, and Major Competitors
    Table 31. Cytori Therapeutics Major Business
    Table 32. Cytori Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
    Table 33. Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Cytori Therapeutics Recent Developments and Future Plans
    Table 35. Intrexon Company Information, Head Office, and Major Competitors
    Table 36. Intrexon Major Business
    Table 37. Intrexon Adipose Derived Stem Cell Therapy Product and Solutions
    Table 38. Intrexon Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Intrexon Recent Developments and Future Plans
    Table 40. Mesoblast Company Information, Head Office, and Major Competitors
    Table 41. Mesoblast Major Business
    Table 42. Mesoblast Adipose Derived Stem Cell Therapy Product and Solutions
    Table 43. Mesoblast Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Mesoblast Recent Developments and Future Plans
    Table 45. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Pluristem Therapeutics Major Business
    Table 47. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
    Table 48. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Pluristem Therapeutics Recent Developments and Future Plans
    Table 50. Tissue Genesis Company Information, Head Office, and Major Competitors
    Table 51. Tissue Genesis Major Business
    Table 52. Tissue Genesis Adipose Derived Stem Cell Therapy Product and Solutions
    Table 53. Tissue Genesis Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Tissue Genesis Recent Developments and Future Plans
    Table 55. BioRestorative Therapies Company Information, Head Office, and Major Competitors
    Table 56. BioRestorative Therapies Major Business
    Table 57. BioRestorative Therapies Adipose Derived Stem Cell Therapy Product and Solutions
    Table 58. BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. BioRestorative Therapies Recent Developments and Future Plans
    Table 60. Celltex Therapeutics Corporation Company Information, Head Office, and Major Competitors
    Table 61. Celltex Therapeutics Corporation Major Business
    Table 62. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Product and Solutions
    Table 63. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Celltex Therapeutics Corporation Recent Developments and Future Plans
    Table 65. iXCells Biotechnologies Company Information, Head Office, and Major Competitors
    Table 66. iXCells Biotechnologies Major Business
    Table 67. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Product and Solutions
    Table 68. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. iXCells Biotechnologies Recent Developments and Future Plans
    Table 70. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
    Table 71. Pluristem Therapeutics Major Business
    Table 72. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
    Table 73. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Pluristem Therapeutics Recent Developments and Future Plans
    Table 75. Cyagen Company Information, Head Office, and Major Competitors
    Table 76. Cyagen Major Business
    Table 77. Cyagen Adipose Derived Stem Cell Therapy Product and Solutions
    Table 78. Cyagen Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. Cyagen Recent Developments and Future Plans
    Table 80. Lonza Company Information, Head Office, and Major Competitors
    Table 81. Lonza Major Business
    Table 82. Lonza Adipose Derived Stem Cell Therapy Product and Solutions
    Table 83. Lonza Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 84. Lonza Recent Developments and Future Plans
    Table 85. Global Adipose Derived Stem Cell Therapy Revenue (USD Million) by Players (2019-2024)
    Table 86. Global Adipose Derived Stem Cell Therapy Revenue Share by Players (2019-2024)
    Table 87. Breakdown of Adipose Derived Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 88. Market Position of Players in Adipose Derived Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 89. Head Office of Key Adipose Derived Stem Cell Therapy Players
    Table 90. Adipose Derived Stem Cell Therapy Market: Company Product Type Footprint
    Table 91. Adipose Derived Stem Cell Therapy Market: Company Product Application Footprint
    Table 92. Adipose Derived Stem Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 93. Adipose Derived Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 94. Global Adipose Derived Stem Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 95. Global Adipose Derived Stem Cell Therapy Consumption Value Share by Type (2019-2024)
    Table 96. Global Adipose Derived Stem Cell Therapy Consumption Value Forecast by Type (2025-2030)
    Table 97. Global Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2024)
    Table 98. Global Adipose Derived Stem Cell Therapy Consumption Value Forecast by Application (2025-2030)
    Table 99. North America Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 100. North America Adipose Derived Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 101. North America Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 102. North America Adipose Derived Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 103. North America Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 104. North America Adipose Derived Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 105. Europe Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 106. Europe Adipose Derived Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 107. Europe Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 108. Europe Adipose Derived Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 109. Europe Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 110. Europe Adipose Derived Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 111. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 112. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 113. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 114. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 115. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 116. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 117. South America Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 118. South America Adipose Derived Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 119. South America Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 120. South America Adipose Derived Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 121. South America Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 122. South America Adipose Derived Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 123. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 124. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 125. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 126. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 127. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 128. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 129. Adipose Derived Stem Cell Therapy Raw Material
    Table 130. Key Suppliers of Adipose Derived Stem Cell Therapy Raw Materials
List of Figures
    Figure 1. Adipose Derived Stem Cell Therapy Picture
    Figure 2. Global Adipose Derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Autologous Stem Cells
    Figure 5. Allogeneic Stem Cells
    Figure 6. Global Adipose Derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application in 2023
    Figure 8. Therapeutic Application Picture
    Figure 9. Research Application Picture
    Figure 10. Global Adipose Derived Stem Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Adipose Derived Stem Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Market Adipose Derived Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 13. Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 14. Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Region in 2023
    Figure 15. North America Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. Europe Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 17. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. South America Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Global Adipose Derived Stem Cell Therapy Revenue Share by Players in 2023
    Figure 21. Adipose Derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 22. Global Top 3 Players Adipose Derived Stem Cell Therapy Market Share in 2023
    Figure 23. Global Top 6 Players Adipose Derived Stem Cell Therapy Market Share in 2023
    Figure 24. Global Adipose Derived Stem Cell Therapy Consumption Value Share by Type (2019-2024)
    Figure 25. Global Adipose Derived Stem Cell Therapy Market Share Forecast by Type (2025-2030)
    Figure 26. Global Adipose Derived Stem Cell Therapy Consumption Value Share by Application (2019-2024)
    Figure 27. Global Adipose Derived Stem Cell Therapy Market Share Forecast by Application (2025-2030)
    Figure 28. North America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 29. North America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 30. North America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 31. United States Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 32. Canada Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 33. Mexico Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 34. Europe Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 35. Europe Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 36. Europe Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 37. Germany Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 38. France Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 39. United Kingdom Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 40. Russia Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. Italy Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 43. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 44. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 45. China Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 46. Japan Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 47. South Korea Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 48. India Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. Southeast Asia Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. Australia Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. South America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 52. South America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 53. South America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 54. Brazil Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 55. Argentina Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 56. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 57. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 58. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 59. Turkey Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 60. Saudi Arabia Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 61. UAE Adipose Derived Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 62. Adipose Derived Stem Cell Therapy Market Drivers
    Figure 63. Adipose Derived Stem Cell Therapy Market Restraints
    Figure 64. Adipose Derived Stem Cell Therapy Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Adipose Derived Stem Cell Therapy in 2023
    Figure 67. Manufacturing Process Analysis of Adipose Derived Stem Cell Therapy
    Figure 68. Adipose Derived Stem Cell Therapy Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Companies Mentioned

AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Pluristem Therapeutics
Cyagen
Lonza